Toho Holdings Co., Ltd. (8129.T)
JPY 4718.0
(-1.09%)
JPY 4718.0
(-1.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 112.98 Billion JPY | 1.96% |
| 2022 | 110.81 Billion JPY | 1.96% |
| 2021 | 108.68 Billion JPY | 9.37% |
| 2020 | 99.37 Billion JPY | -13.9% |
| 2019 | 115.41 Billion JPY | 3.01% |
| 2018 | 112.04 Billion JPY | -1.87% |
| 2017 | 114.17 Billion JPY | 3.8% |
| 2016 | 109.99 Billion JPY | -12.65% |
| 2015 | 125.92 Billion JPY | 18.44% |
| 2014 | 106.32 Billion JPY | 1.16% |
| 2013 | 105.1 Billion JPY | 3.04% |
| 2012 | 101.99 Billion JPY | 4.88% |
| 2011 | 97.25 Billion JPY | 12.9% |
| 2010 | 86.14 Billion JPY | 5.8% |
| 2009 | 81.42 Billion JPY | 30.62% |
| 2008 | 62.33 Billion JPY | -5.45% |
| 2007 | 65.92 Billion JPY | 3.61% |
| 2006 | 63.63 Billion JPY | 22.55% |
| 2005 | 51.92 Billion JPY | 18.04% |
| 2004 | 43.98 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 27.69 Billion JPY | -10.96% |
| 2023 Q2 | 29.74 Billion JPY | 10.61% |
| 2023 FY | 112.98 Billion JPY | 1.96% |
| 2023 Q1 | 26.89 Billion JPY | -6.29% |
| 2023 Q4 | 31.1 Billion JPY | 9.84% |
| 2023 Q3 | 28.31 Billion JPY | -4.8% |
| 2022 Q3 | 29.21 Billion JPY | 6.63% |
| 2022 Q2 | 27.39 Billion JPY | 7.37% |
| 2022 Q1 | 25.51 Billion JPY | -17.07% |
| 2022 FY | 110.81 Billion JPY | 1.96% |
| 2022 Q4 | 28.69 Billion JPY | -1.75% |
| 2021 Q2 | 25.79 Billion JPY | 4.15% |
| 2021 FY | 108.68 Billion JPY | 9.37% |
| 2021 Q1 | 24.76 Billion JPY | 0.45% |
| 2021 Q3 | 27.35 Billion JPY | 6.04% |
| 2021 Q4 | 30.76 Billion JPY | 12.47% |
| 2020 Q1 | 25.28 Billion JPY | -11.7% |
| 2020 Q2 | 23.78 Billion JPY | -5.96% |
| 2020 Q3 | 25.64 Billion JPY | 7.82% |
| 2020 Q4 | 24.65 Billion JPY | -3.84% |
| 2020 FY | 99.37 Billion JPY | -13.9% |
| 2019 Q2 | 29.07 Billion JPY | 5.05% |
| 2019 Q4 | 28.63 Billion JPY | -4.59% |
| 2019 FY | 115.41 Billion JPY | 3.01% |
| 2019 Q1 | 27.68 Billion JPY | -7.32% |
| 2019 Q3 | 30.01 Billion JPY | 3.22% |
| 2018 Q3 | 29.79 Billion JPY | 12.2% |
| 2018 Q4 | 29.86 Billion JPY | 0.25% |
| 2018 FY | 112.04 Billion JPY | -1.87% |
| 2018 Q1 | 25.83 Billion JPY | -18.54% |
| 2018 Q2 | 26.55 Billion JPY | 2.8% |
| 2017 Q4 | 31.71 Billion JPY | 8.39% |
| 2017 Q3 | 29.25 Billion JPY | 8.36% |
| 2017 Q2 | 26.99 Billion JPY | 3.01% |
| 2017 Q1 | 26.21 Billion JPY | -2.58% |
| 2017 FY | 114.17 Billion JPY | 3.8% |
| 2016 Q2 | 27.91 Billion JPY | 0.53% |
| 2016 Q3 | 27.41 Billion JPY | -1.79% |
| 2016 FY | 109.99 Billion JPY | -12.65% |
| 2016 Q4 | 26.9 Billion JPY | -1.85% |
| 2016 Q1 | 27.76 Billion JPY | -30.03% |
| 2015 FY | 125.92 Billion JPY | 18.44% |
| 2015 Q3 | 32.2 Billion JPY | 16.96% |
| 2015 Q4 | 39.68 Billion JPY | 23.22% |
| 2015 Q2 | 27.53 Billion JPY | 3.89% |
| 2015 Q1 | 26.5 Billion JPY | 2.68% |
| 2014 Q3 | 29.31 Billion JPY | 21.76% |
| 2014 Q4 | 25.81 Billion JPY | -11.94% |
| 2014 FY | 106.32 Billion JPY | 1.16% |
| 2014 Q1 | 27.12 Billion JPY | 6.29% |
| 2014 Q2 | 24.07 Billion JPY | -11.26% |
| 2013 Q2 | 25.98 Billion JPY | 2.98% |
| 2013 Q4 | 25.52 Billion JPY | -10.02% |
| 2013 FY | 105.1 Billion JPY | 3.04% |
| 2013 Q1 | 25.23 Billion JPY | -5.84% |
| 2013 Q3 | 28.36 Billion JPY | 9.14% |
| 2012 Q3 | 25.1 Billion JPY | -2.64% |
| 2012 FY | 101.99 Billion JPY | 4.88% |
| 2012 Q1 | 24.3 Billion JPY | -11.84% |
| 2012 Q2 | 25.78 Billion JPY | 6.09% |
| 2012 Q4 | 26.8 Billion JPY | 6.75% |
| 2011 Q4 | 27.57 Billion JPY | 12.23% |
| 2011 FY | 97.25 Billion JPY | 12.9% |
| 2011 Q1 | 22.36 Billion JPY | 15.41% |
| 2011 Q2 | 22.74 Billion JPY | 1.69% |
| 2011 Q3 | 24.56 Billion JPY | 8.0% |
| 2010 Q1 | 22.46 Billion JPY | -4.2% |
| 2010 Q4 | 19.38 Billion JPY | -10.94% |
| 2010 FY | 86.14 Billion JPY | 5.8% |
| 2010 Q3 | 21.76 Billion JPY | -3.39% |
| 2010 Q2 | 22.52 Billion JPY | 0.28% |
| 2009 Q4 | 23.45 Billion JPY | 7.09% |
| 2009 Q1 | 17.89 Billion JPY | 49.05% |
| 2009 Q2 | 18.17 Billion JPY | 1.54% |
| 2009 FY | 81.42 Billion JPY | 30.62% |
| 2009 Q3 | 21.89 Billion JPY | 20.49% |
| 2008 Q2 | 16.91 Billion JPY | 0.0% |
| 2008 Q3 | 16.63 Billion JPY | -1.66% |
| 2008 Q4 | 12 Billion JPY | -27.79% |
| 2008 FY | 62.33 Billion JPY | -5.45% |
| 2007 FY | 65.92 Billion JPY | 3.61% |
| 2006 FY | 63.63 Billion JPY | 22.55% |
| 2005 FY | 51.92 Billion JPY | 18.04% |
| 2004 FY | 43.98 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -131.755% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 94.829% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 39.896% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 69.388% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -3090.902% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | -16.459% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -195.602% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 80.733% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -1783.711% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -43.072% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -116.987% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -735.873% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -1360.132% |
| Tsumura & Co. | 68.81 Billion JPY | -64.182% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -202.576% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -355.732% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -38.831% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -584.136% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -125.153% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -119.815% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -10371.27% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -1048.338% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -2461.429% |
| MedRx Co., Ltd | 26 Million JPY | -434457.692% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -1307.787% |
| Solasia Pharma K.K. | 337 Million JPY | -33426.706% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 15456324.35% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -268.449% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -108.003% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -299245.591% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -1601.683% |